David Kent holds a PhD in Genetics (UBC) and a BSc in Genetics and English (UWO) and is currently a CIHR postdoctoral fellow at the University of Cambridge, UK. He studies normal and malignant stem cell biology and currently sits on the executive for the Canadian Association of Postdoctoral Scholars. He also maintains his own blog for early career researchers at University Affairs, called the Black Hole (http://www.universityaffairs.ca/the-black-hole/).
Posts by: David
> Last Friday was the final day of the Till & McCulloch Meetings in Banff, which was a great display of collaborative stem cell projects going on across the country. I’ll emphasize again how wonderful this meeting is for getting a broad survey of research in adult and pluripotent stem cells without having to wade…Read more
> Day 2 of TMM2013 began with a video link shared session between this meeting here in Banff and another happening in Leipzig. It was a pretty cool idea and underscores two neat things about the Canadian Stem Cell Network and CCRM. First, despite being viewed as a national stem cell network meeting there is…Read more
> Set in the beautiful mountain setting of Banff National Park, the first hours of the Till and McCulloch meeting have not disappointed. Our morning plenary began with an excellent historical perspective from Shin-Ichi Nishikawa on the origins of blood stem cells and rolled on through an excellent series of talks on epigenetic regulation and…Read more
. Stem cells must strike a balance between different types of divisional outcomes in order to provide the correct numbers and types of cells for the lifetime of an organism. At each cell division, a stem cell either makes two replicates of itself to expand the population (a self-renewal division), makes two highly proliferating cells…Read more
As a basic researcher in stem cell biology, one of my biggest fears is moving too quickly with cell therapies that involve primitive, still largely mysterious, cell populations. At the World Stem Cells & Regenerative Medicine Congress meeting this week, I felt much better about the direction that regenerative medicine is headed. It has been…Read more
You might expect this article to be about creating skin grafts for burn victims or something of that ilk. Instead though, it concerns the complicated process of taking a scientific discovery in regenerative medicine and bringing that discovery through clinical trials or commercialization to help people. If you imagine the middle of an onion as…Read more